Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Sep 2, 2026
Effects of erector spinae plane block on postoperative pain in patients undergoing implant-based breast reconstruction for breast cancer: a randomized controlled trial.
Read at PubMed CentralPubMed Central · Sep 2, 2026
KRAS is required for plexiform neurofibroma formation and represents a targetable vulnerability in established tumors.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Core components of physical activity interventions in the prevention and management of breast cancer-related lymphoedema (BCRL): A scoping review.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Bifidobacterium animalis subsp. lactis V9 overcomes CYFRA 21-1-linked immunochemotherapy resistance in NSCLC via microbial metabolites.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Amanitin-Based Fc-Small Molecule-Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Preoperative CT-based 3D analysis of middle colic vein anatomy for complete mesocolic excision in right-sided colon cancer: a retrospective cohort study from a prospective clinical trial.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Multi-omics integration uncovers epigenetic control of metabolic reprogramming in triple-negative breast cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
MR-based radiomics of mesorectal fat for improved prediction of perirectal lymph node metastasis and extramural venous invasion in locally advanced rectal cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.
Read at PubMed CentralPubMed Central · Sep 2, 2026
VISTA+ Neutrophils Contribute to Platinum Resistance by Suppressing CD8+ T Cells in High-Grade Serous Ovarian Cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.
Read at PubMed CentralPubMed Central · Sep 2, 2026
M6 Metabolite Contributes to the Efficacy of the Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Breast Cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer.
Read at PubMed CentralPubMed Central · Sep 2, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.
Read at PubMed CentralAmerican Cancer Society · Sep 1, 2026
Prostate Cancer Awareness Month: American Cancer Society Reports New Cases Are Up 3% but Earlier Diagnosis Improves Patient Outcomes
Read at American Cancer SocietyAmerican Cancer Society · Sep 1, 2026
Mes de concienciación sobre el cáncer de próstata: La American Cancer Society informa de que los nuevos casos han aumentado un 3 %, pero que el diagnóstico temprano mejora los resultados de los pacientes
Read at American Cancer SocietyPubMed Central · Sep 1, 2026
Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer after Progression on First-line Osimertinib: Phase II ORCHARD Study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
The Landscape of Genomic and Socioeconomic Variables in Patients with Colorectal Cancer Based on Genetic Ancestry.
Read at PubMed Central